Panel testing can identify women who are at increased risk for breast cancer. However, those at risk for triple-negative breast cancer cannot easily be identified because other than BRCA1, genes that increase the risk for triple-negative breast cancer are unknown. A new study uses panel testing to identify which genes increase the risk for triple-negative breast cancer. (8/23/18)
The National Comprehensive Cancer Network (NCCN) guidelines currently recommend BRCA1 and BRCA2 testing for women diagnosed with triple-negative breast cancer (TNBC) at age 60 or younger or those who meet criteria based on a personal or family history of cancer.
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.